Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6M Sell
208,911
-32,188
-13% -$1.43M ﹤0.01% 1954
2026
Q1
$9.84M Buy
241,099
+142,879
+145% +$7.39M ﹤0.01% 1935
2025
Q4
$6.3M Buy
98,220
+12,820
+15% +$1.06M ﹤0.01% 2268
2025
Q3
$9.08M Sell
85,400
-73,410
-46% -$6.18M ﹤0.01% 1985
2025
Q2
$10.4M Sell
158,810
-6,069
-4% -$312K ﹤0.01% 1799
2025
Q1
$6.33M Buy
164,879
+74,681
+83% +$3.22M ﹤0.01% 2130
2024
Q4
$3.71M Buy
90,198
+9,878
+12% +$435K ﹤0.01% 2573
2024
Q3
$3.16M Buy
+80,320
New +$2.81M ﹤0.01% 2677

Other funds holding LIF

Ameriprise's LIF Position: Q2 2026 in Review

Ameriprise reduced its Life360 (LIF) stake by 13% in Q2 2026, selling an estimated $1.43M and leaving 208,911 shares worth $11.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1954.

Ameriprise first reported a position in LIF in Q3 2024 and has held it in 8 quarters since. 202 funds tracked by Wall St. Rank hold LIF as of Q2 2026.

  • Ameriprise held 208,911 shares of Life360 worth $11.6M as of Q2 2026.
  • Ameriprise sold 32,188 Life360 shares in Q2 2026, an estimated $1.43M.
  • Life360 made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #1954 holding.
  • Ameriprise first reported a position in Life360 in Q3 2024 and has held it in 8 quarters since.
  • 202 funds tracked by Wall St. Rank held Life360 as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.